Home・Elenco Azioni・Novartis AG

Novartis AG

Aperta

153.89 -1.03

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

154.68

Massimo

157.05

Metriche Chiave
By Trading Economics
Entrata	747M 3.2B
Vendite	189M 14B
P/E Media del settore	22.245 60.549
EPS	1.65
Rendimento da dividendi	3.05
Margine di Profitto	23.336
Dipendenti	75,267
EBITDA	338M 5.4B

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+8.9% upside

Dividendi
By Acuity
Rendimento da dividendi Media del settore	3.05% 2.22%

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	18B 297B
Apertura precedente	154.92
Chiusura precedente	153.89

Novartis AG Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 lug 2026, 23:56 UTC

Macro News

ETF Constituents

Correlated Moves

Social Media

Financial Select Sector SPDR Fund declines in after-market trading amid escalating Middle East tensions and concerns over oil supply routes affecting inflation and Fed policy.

7 lug 2026, 23:56 UTC

Correlated Moves

NXP Semiconductors NV shares are lower in after-market hours, following a decline in the Nasdaq 100 Index and amid ongoing geopolitical tensions.

7 lug 2026, 23:56 UTC

ETF Constituents

The iShares China Large-Cap ETF showed minimal movement in after-market hours, reflecting broader market trends amid concerns over valuations and geopolitical tensions.

7 lug 2026, 23:56 UTC

Macro News

ETF Constituents

Correlated Moves

ROBO shares advanced in after-market hours, supported by gains from top holdings IPGP and ISRG amid rising crude oil prices and geopolitical tensions.

7 lug 2026, 23:56 UTC

Macro News

Correlated Moves

The US 30Y Treasury Bond Index is trading lower amid heightened geopolitical tensions following U.S. military strikes against Iran and rising crude oil prices.

7 lug 2026, 23:56 UTC

Macro News

ETF Constituents

Health Care Select Sector SPDR Fund trades higher after-market, supported by gains in LLY, MDT, and JNJ, despite rising crude oil prices and broader market pressures.

7 lug 2026, 23:52 UTC

Global equity markets decline amid rising geopolitical tensions, tech stock pullbacks, and widening U.S. trade deficit.

7 lug 2026, 23:52 UTC

Asia equity markets mixed as Nikkei and Hang Seng decline amid AI boom concerns and geopolitical tensions, while U.S. Treasury yields rise on increased volatility.

7 lug 2026, 23:52 UTC

European equity markets show mixed results amid geopolitical tensions, with Germany's DAX down 1.3% despite stronger industrial production, while France's trade deficit widens and the euro weakens against the dollar.

7 lug 2026, 23:52 UTC

U.S. equity indices decline amid widening trade deficit and geopolitical tensions, with tech stocks particularly affected.

7 lug 2026, 23:51 UTC

Correlated Moves

The SGD/CHF has advanced during Tuesday's session, reflecting a steady increase since Monday's close, supported by a rise in USD/CHF.

7 lug 2026, 23:51 UTC

Social Media

Correlated Moves

Intuit Inc. shares fell in after-market trading, mirroring a decline in the Nasdaq 100 Index. The stock's price-to-earnings ratio is 17 times earnings.

7 lug 2026, 23:51 UTC

Microchip Technology Inc shares are higher in after-market hours, reflecting a modest gain since Tuesday's close amid routine trading activity.

7 lug 2026, 23:51 UTC

Brazil's Central Bank to announce interest rate decision on July 13, 2026, amid cautious sentiment over inflation and economic growth.

7 lug 2026, 23:51 UTC

Japan's Machinery Orders Data Release on July 14 Expected to Reflect Recovery Amid Mixed Economic Sentiment and Rising Household Spending.

7 lug 2026, 23:51 UTC

News

Netflix is reportedly bidding for FIFA World Cup U.S. rights valued at $2 billion, boosting positive sentiment as shares rise in after-market trading.

7 lug 2026, 23:51 UTC

American Airlines Group shares declined in after-market trading, continuing a trend of lower daily closes amid a widening U.S. trade deficit.

7 lug 2026, 23:51 UTC

Correlated Moves

The USD/CZK is higher today, reflecting a modest increase since Monday's close, amid broader gains in correlated assets like the USD/CHF.

7 lug 2026, 23:51 UTC

JD.Com Inc shares are trading higher in after-market hours, though no specific news has been identified to explain the movement.

7 lug 2026, 23:51 UTC

Correlated Moves

Lam Research Corp shares are lower in after-market trading amid a broader market downturn and ongoing geopolitical tensions. The stock has declined for four consecutive sessions.

7 lug 2026, 23:51 UTC

Correlated Moves

KLA Corp shares are lower in after-market trading, influenced by a widening U.S. trade deficit of $77.6 billion and rising interest rate concerns.

7 lug 2026, 23:51 UTC

Correlated Moves

Applied Materials Inc shares are lower in after-market hours, reflecting broader market declines and ongoing economic concerns, including a widening U.S. trade deficit.

7 lug 2026, 23:51 UTC

Social Media

Correlated Moves

Western Digital Corp shares declined in after-market trading, reflecting broader market trends as the Nasdaq 100 Index also fell. The asset remains below its 20-day moving average.

7 lug 2026, 23:46 UTC

eBay Inc shares are lower in after-market hours amid no specific news. The U.S. trade deficit widened in May, impacting market sentiment.

7 lug 2026, 23:46 UTC

Macro News

ETF Constituents

Crude oil prices rose amid U.S.-Iran tensions, potentially impacting biotechnology costs. iShares Biotechnology ETF traded near unchanged during after-market hours.

7 lug 2026, 23:46 UTC

Macro News

ETF Constituents

COPX is higher in after-market hours, supported by strong performances from Freeport-McMoRan and Southern Copper amid rising crude oil prices and geopolitical tensions.

7 lug 2026, 23:46 UTC

Trip.com Group Ltd shares declined in after-market trading, pulling back from a session high and remaining below their 20-day moving average.

7 lug 2026, 23:46 UTC

Lululemon Athletica Inc shares are lower in after-market hours amid broader concerns over the U.S. trade deficit, which widened to $77.6 billion in May.

7 lug 2026, 23:46 UTC

Terra is trading higher during Tuesday's session, despite pulling back from earlier highs. It remains above its 20-day moving average.

7 lug 2026, 23:46 UTC

ETF Constituents

Macro News

Correlated Moves

The iShares MSCI South Korea ETF is lower in after-market hours, influenced by rising crude oil prices and declines in major indices.

Confronto tra pari

Modifica del prezzo

Novartis AG Previsione

Obiettivo di Prezzo

By TipRanks

8.9% in crescita

Previsioni per 12 mesi

Media 171.01 USD 8.9%

Alto 180 USD

Basso 160 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Novartis AG - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 3 che hanno fornito valutazioni azionarie a Novartis AG - Dist negli ultimi 3 mesi.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Novartis AG

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. The company has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. It also has a research collaboration and license agreement with Schrödinger, Inc. to identify and develop various therapeutic candidates; and a strategic collaboration with Vyriad, Inc. for the discovery and development for vivo chimeric antigen receptor T-cell therapies. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.